首页> 美国卫生研究院文献>AAPS PharmSciTech >The Control of Skin-Permeating Rate of Bisoprolol by Ion-Pair Strategy for Long-Acting Transdermal Patches
【2h】

The Control of Skin-Permeating Rate of Bisoprolol by Ion-Pair Strategy for Long-Acting Transdermal Patches

机译:长效透皮贴剂的离子对策略控制比索洛尔的透皮率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A moderate drug permeating rate (flux) is desirable for long-acting transdermal patches. In this work, a novel simple method of controlling bisoprolol (BSP) flux by ion-pair strategy was initiated. Different ion-pair complexes including bisoprolol maleate (BSP-M), bisoprolol tartarate, bisoprolol besilate, and bisoprolol fumarate were prepared and their fluxes through rabbit abdominal skin were determined separately in vitro. Furthermore, permeation behavior from isopropyl myristate, solubility index in pressure-sensitive adhesives, determined by DSC, and n-octanol/water partition coefficient (log P) were investigated to illustrate the mechanism of drug permeation rate controlling. The results showed that compared to free BSP (J = 25.98 ± 2.34 μg/cm2/h), all BSP ion-pair complexes displayed lower and controllable flux in the range of 0.11 to 4.19 μg/cm2/h. After forming ion-pair complexes, the capability of BSP to penetrate through skin was weakened due to the lowered log P and increased molecule weight. Accordingly, this study has demonstrated that the flux of BSP could be controlled by ion-pair strategy, and among all complexes investigated, BSP-M was the most promising candidate for long-acting transdermal patches.
机译:对于长效透皮贴剂,中等的药物渗透速率(通量)是理想的。在这项工作中,提出了一种通过离子对策略控制比索洛尔(BSP)流量的新颖简单方法。制备了不同的离子对复合物,包括马来酸比索洛尔(BSP-M),酒石酸比索洛尔,硅酸比索洛尔和富马酸比索洛尔,并分别测定了它们在兔腹部皮肤中的通量。此外,研究了肉豆蔻酸异丙酯的渗透行为,DSC测定的在压敏胶粘剂中的溶解度指数以及正辛醇/水分配系数(log P),以说明药物渗透速率的控制机制。结果表明,与游离BSP相比(J = 25.98±2.34μg/ cm 2 / h),所有BSP离子对络合物均显示出较低且可控制的通量,范围为0.11至4.19μg/ cm 2 / h。形成离子对络合物后,由于log P降低和分子量增加,BSP渗透皮肤的能力减弱。因此,这项研究表明BSP的通量可以通过离子对策略来控制,并且在所有研究的复合物中,BSP-M是长效透皮贴剂的最有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号